Title |
Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells
|
---|---|
Published in |
PLOS ONE, October 2013
|
DOI | 10.1371/journal.pone.0078283 |
Pubmed ID | |
Authors |
Tania Romacho, Laura A. Villalobos, Elena Cercas, Raffaele Carraro, Carlos F. Sánchez-Ferrer, Concepción Peiró |
Abstract |
Visfatin is a multifaceted adipokine whose circulating levels are enhanced in different metabolic diseases. Extracellular visfatin can exert various deleterious effects on vascular cells, including inflammation and proliferation. Limited evidence exists, however, on the capacity of human vascular cells to synthesize and release visfatin by themselves, under basal or pro-inflammatory conditions. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Czechia | 1 | 3% |
France | 1 | 3% |
Saudi Arabia | 1 | 3% |
Unknown | 33 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 17% |
Student > Doctoral Student | 5 | 14% |
Researcher | 4 | 11% |
Student > Master | 3 | 8% |
Student > Bachelor | 3 | 8% |
Other | 5 | 14% |
Unknown | 10 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 9 | 25% |
Medicine and Dentistry | 8 | 22% |
Agricultural and Biological Sciences | 4 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Chemistry | 1 | 3% |
Other | 0 | 0% |
Unknown | 12 | 33% |